Equity (Tables)

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

	Number of Warrants
	Equity classified	Liability classified	Total	Weighted average exercise price
Outstanding at December 31, 2019	8,437,747	22,988,501	31,426,248	$	1.12
Exercises	(8,342,128)	(9,392,445)	(17,734,573)	0.77
Issuance	196,850	—	196,850	2.54
Outstanding at September 30, 2020	292,469	13,596,056	13,888,525	$	1.58

Schedule of Authorized Shares of Common Stock for Future Issuance

The Company has authorized shares of common stock for future issuance as follows:

	Period ended
	September 30, 2020	December 31, 2019
Exercise of common warrants	13,888,525	31,426,248
Shares available for future stock incentive awards	5,237,969	1,765,018
Unvested restricted stock units	98,438	181,250
Outstanding common stock options	7,487,154	6,796,669
Total	26,712,086	40,169,185